Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,527,309
+$28,127,346 QoQ
Shares Held
657,641
+610.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#72
of 1,348 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $2,100,933,315 across 14 Drug Manufacturers - General names. NVO ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
694,293 | $832,755,921 | |
| 2 | AZN |
Astrazeneca PLC
|
2,332,566 | $442,301,164 | |
| 3 | JNJ |
Johnson & Johnson
|
1,364,685 | $346,589,048 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,843,591 | $236,901,443 | |
| 5 | ABBV |
AbbVie Inc.
|
254,499 | $64,042,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,063,855 | $61,299,324 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
284,948 | $36,000,330 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
657,641 | $31,527,309 |
All Filings in NVO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,527,309 | 657,641 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,399,963 | 92,516 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $43,746,929 | 859,806 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $78,880,477 | 1,421,526 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $87,253,841 | 1,264,182 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $85,938,527 | 1,237,594 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $109,062,435 | 1,267,873 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $156,389,276 | 1,313,423 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $164,936,070 | 1,155,500 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $158,944,562 | 1,237,886 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $150,953,619 | 1,459,194 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $135,883,821 | 1,494,214 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $85,700,960 | 529,574 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $864,925 | 5,435 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $715,677 | 5,288 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $615,314 | 6,176 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,451 | 22 | Shares | Sole | 2022-08-09 | |
| No filing history on record for this holder in this stock. | ||||||